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ABSTRACT
The epithelial-mesenchymal transition (EMT) represents a cellular de-
differentiation process that provides cells with the increased plasticity required during 
embryonic development, tissue remodeling, wound healing and metastasis. Slug and 
Twist are two key EMT transcription factors (EMT-TFs) that are tightly regulated via 
ubiquitination and degradation. How Slug and Twist escape degradation and become 
stabilized in cancer cells remains unclear. One plausible mechanism of Slug and Twist 
stabilization involves removal of ubiquitin by deubiquitinases (DUBs). In this study, 
we identified Dub3 as a novel DUB for both Slug and Twist. We further found that 
Dub3 overexpression increased Slug and Twist protein levels in a dose-dependent 
manner, whereas Dub3-knockdown decreased their protein levels. Of importance, 
Dub3 interacted with Slug and Twist and prevented them from degradation, thereby 
promoting migration, invasion, and cancer stem cell (CSC)-like properties of breast 
cancer cells. Intriguingly, Dub3 was identified as an early response gene that was 
upregulated after exposure to inflammatory cytokines such as IL-6, which plays 
a critical role in the growth and metastasis of breast cancer cells, as well as the 
maintenance of breast CSCs. We found that Dub3 played an essential role in IL-6 
induced EMT through stabilization of Slug and Twist. Our study has uncovered an 
IL-6-Dub3-Slug/Twist signaling axis during EMT and suggests potential approaches 
that could target Dub3 to prevent metastatic breast tumor.
INTRODUCTION
Originally recognized as a vital cellular process 
during embryonic morphogenesis, EMT has been linked 
to pathologies including fibrosis and cancer progression, 
due to the similarities in the migratory and invasive 
characteristics that the cells obtain during these processes 
[1-4]. Indeed, growing evidence indicates that EMT 
endows tumor cells with CSC-like traits, renders 
them resistant to therapeutics and provides them with 
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proclivity for early metastasis. While EMT is required 
for dissociation of tumor cells from primary carcinomas 
and their subsequent migration and dissemination, it is the 
reversal process mesenchymal-epithelial transition (MET), 
that directs tumor cells to regain epithelial properties and 
proliferate at metastatic sites [5, 6]. Not surprisingly, EMT 
is executed and tightly regulated in response to different 
levels of signaling integrative of transcriptional control, 
epigenetic modifications as well as protein stability and 
subcellular localization [2, 7-15].
Classical EMT-TFs fall into three groups: Snail 
family zinc finger proteins (Snail/Snail1 and Slug/Snail2); 
Twist family basic helix-loop-helix (bHLH) proteins 
(Twist/Twist1 and Twist2); and ZEB family two-handed 
zinc finger/homeodomain proteins (ZEB1 and ZEB2/SIP-
1). Aberrant expression/activation of EMT-TFs can give 
rise to tumor angiogenesis, invasion and metastasis, confer 
tumor cells with CSC-like properties as well as resistance 
to apoptosis. For example, our previous studies along 
with others’ demonstrated that Snail expression correlates 
with tumor grade and nodal metastasis of invasive ductal 
carcinoma [14, 16]; and Slug overexpression prior to 
neoplastic transformation predisposes BRCA1-mutation 
carriers to aggressive basal-like breast cancer (BLBC) 
[17]; and Twist is highly expressed in invasive lobular 
carcinoma [18]. EMT-TFs are under multiple layers of 
control. With respect to protein stability, the Snail family 
members and Twist are extremely labile proteins subject 
to poly-ubiquitination and degradation mediated by E3 
ubiquitin ligases including β-TrCP, Fbxl14, Fbxl5, Fbxo11 
and Mdm2 [19].
Ubiquitination is a reversible process, as 
ubiquitin moieties can be removed from proteins 
by deubiquitinases (DUBs). DUBs consist of five 
enzyme families: ubiquitin-specific proteases (USPs), 
ubiquitin C-terminal hydrolases (UCHs), Machado-
Josephin domain proteases (MJDs), ovarian tumor 
proteases (OTUs) and Jab1/Mov34/MPN+ (JAMM) 
domain-containing metalloenzymes. Recent studies 
demonstrated that DUBs play essential roles in cancer 
development through regulation of transcription, DNA 
repair and cell cycle progression [20]. As such, DUBs 
have emerged as promising targets of anti-cancer 
therapies [21]. It is speculative yet interesting to find 
out whether ubiquitination of Snail family and Twist 
transcription factors is counteracted by DUBs under 
specific conditions, such that these transcription factors 
escape degradation and become stabilized to promote 
EMT and metastasis. As a member of USPs, Dub3 is 
an immediate early gene whose transcription can be 
rapidly induce by cytokines [20, 22, 23]. Importantly, 
high expression of Dub3 in mouse embryonic stem cells 
(ESCs) couples the G1/S checkpoint with pluripotency 
through Cdc25A de-ubiquitination, and Dub3 depletion 
reduces the proliferative potential of breast cancer cells 
in vivo by degradation of Cdc25A [24, 25].
In the current study, we identified Dub3 as a new 
DUB of Slug and Twist. We found that Dub3 interacted with 
and stabilized Slug and Twist through de-ubiquitination. 
Furthermore, we demonstrated that Dub3 promoted migration, 
invasion and CSC-like properties of breast cancer cells. 
Together, our study identifies a novel role of Dub3 in inducing 
EMT through Slug and Twist stabilization, and strengthens 
the potential of Dub3 as an anti-cancer drug target.
RESULTS
Dub3 stabilizes Slug and Twist
To identify specific DUBs involved in mediating protein 
stability of the Slug, we performed a screening of siRNA 
library targeting the 99 known or putative DUBs. Based on 
the initial screening, we identified two potential candidates, 
USP28 and Dub3 (data not shown). However, we found that 
only Dub3, but not USP28, interacted with Slug (top panel, 
Figure 1A). When Dub3 was co-expressed with Slug in 
HEK293 cells, we found that Dub3 significantly increased 
protein levels of Slug, an effect comparable to treatment 
with proteasome inhibitor MG132 (top panel, Figure 1B). 
Because degradation of both Slug and Twist is mediated by 
β-TrCP1 and Fbxl14, and DUBs usually counteract E3 ligases 
to stabilize their target proteins, we asked whether Dub3 
also stabilizes Twist. Surprisingly, Dub3 also significantly 
increased Twist protein (bottom panel, Figure 1B). In contrast, 
a Dub3 mutant, in which the catalytic cysteine was replaced 
with serine (C89S, CS), had no effect on Slug/Twist protein 
levels, indicating that Dub3 enzymatic activity is required 
for Slug/Twist stabilization (Figure 1C). Similar to Slug, 
Twist also interacted with Dub3 but not USP28 (bottom 
panel, Figure 1A). In addition, when we co-expressed Slug/
Twist with increasing amounts of Dub3 in HEK293 cells, the 
levels of Slug and Twist increased in a Dub3 dose-dependent 
manner (Figure 1D). To test whether endogenous Slug and 
Twist are subject to similar regulation, we knocked down 
Dub3 expression in basal-like breast cancer (BLBC) cells 
MDA-MB157 and SUM159 and found that the protein levels 
of Slug and Twist, rather than mRNA levels of these two 
molecules, significantly decreased in these cells (Figure 1E). 
This excludes the possibility that Dub3 indirectly regulates 
transcription rather than protein stability of Slug and Twist. 
Furthermore, MG132 treatment restored the downregulation 
of Slug and Twist in Dub3-knockdown MDA-MB157 cells 
(Figure 1F). Collectively, our data indicated that Dub3 is 
involved in mediating the protein stability of Slug and Twist.
Dub3 interacts with Slug and Twist
To further define the mechanism of Dub3-
mediated Slug and Twist stabilization, we performed 
co-immunoprecipitation (Co-IP) experiment using 
HEK293 cells expressing both Myc-Dub3 and Flag-Slug 
or HA-Twist. After IP of Dub3, we detected associated 
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Figure 1: Dub3 stabilized Slug and Twist. (A) Flag-tagged Slug and HA-tagged DUBs or HA-Twist and Flag-tagged DUBs were 
co-expressed in HEK293 cells. After immunoprecipitation, bound Slug or Twist was examined by western blot. (B) Flag-Slug or Flag-Twist 
was expressed with or without Myc-Dub3 in HEK293 cells or treated with MG132 only. Expression of Slug, Twist and Dub3 was examined 
by western blot analysis. (C) Flag-Slug or Flag-Twist was co-expressed with wild-type (WT) or C89S (CS) mutant Dub3 in HEK293 cells 
and examined by western blot analysis. (D) Flag-Slug or Flag-Twist was co-expressed with increasing amounts of Myc-Dub3 in HEK293 
cells and examined by western blot analysis. (E) MDA-MB157 and SUM159 cells were stably transfected with control or Dub3 shRNAs 
and the expression of Slug, Twist and Dub3 was examined by western blot analysis. The mRNAs of Slug, Twist and Dub3 in MDA-MB157 
and SUM159 cells stably transfected with control or Dub3 shRNA were examined by real-time PCR. (F) MDA-MB157 cells stably 
transfected with control or Dub3 shRNA were treated with or without MG132 and expression of Slug, Twist and Dub3 was examined. *p 
value < 0.001; #p value > 0.05.
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Slug/Twist, and vice versa (Figure 2A). Concurrently, 
we also performed endogenous Co-IP and confirmed the 
association of Dub3 with Slug and Twist in MDA-MB157 
and SUM159 cells (Figure 2B). The Dub3-Slug/Twist 
interaction was further supported by immunofluorescence 
(IF) analysis, as Myc-Dub3 co-localized with GFP-Slug 
or GFP-Twist in the nuclei of HEK293 cells (Figure 2C).
Dub3 deubiquitinates Slug and Twist
To test the effect of Dub3 on the protein stability 
of Slug and Twist, we co-expressed Slug/Twist with 
Dub3 or vector control in HEK293 cells and treated cells 
with cycloheximide (CHX) at different time intervals to 
block newly synthesized protein. Both Slug and Twist 
proteins became significantly stabilized in presence of 
Dub3 compared to vector control group (Figure 3A). 
Consistently, CHX chase experiments showed that 
endogenous Slug and Twist became unstable and degraded 
rapidly upon knockdown of Dub3 in MDA-MB157 cells 
(Figure 3B). In Slug or Twist expressing HEK293 cells 
treated with MG132, IP of Slug/Twist showed that both 
proteins were heavily ubiquitinated (lane 1 of both upper 
panels, Figure 3C). Co-expression of wild-type (WT) Dub3 
almost completely abolished ubiquitination of Slug and 
Twist, while co-expression of CS-Dub3 did not show this 
effect (lane 2 vs lane 3 in both upper panels, Figure 3C). 
Conversely, the level of Slug and Twist ubiquitination was 
significantly increased upon Dub3-knockdown in MDA-
MB157 and SUM159 cells (Figure 3D). Taken together, 
our results demonstrated that Slug and Twist associate with 
Dub3 and are subject to Dub3-mediated de-ubiquitination, 
which contributes to their protein stabilization.
Dub3 mediates migration, invasion and CSC-like 
properties of breast cancer cells
To investigate the function of Dub3 in breast cancer, 
we established stable MDA-MB157 and SUM159 cells 
with knockdown of Dub3 expression. Dub3-knockdown 
increased the expression of epithelial markers E-cadherin 
and Claudin-7, while down-regulating mesenchymal 
molecules N-cadherin and Vimentin (Figure 4A). In 
addition, both cells with Dub3-knockdown showed 
reduced levels of molecules associated with BLBC such 
as CK5, EGFR, SPARC and Caveolin-1, and gained 
expression of luminal markers such as CK18 and ERα 
(Figure 4B). We then performed migration and invasion 
assays and found that Dub3-knockdown significantly 
decreased migratory and invasive capabilities of MDA-
MB157 and SUM159 cells (Figure 4C-4D). Furthermore, 
to assess the effect of Dub3 in regulating CSC-like 
properties, we performed tumorsphere-formation assays 
and found that Dub3-knockdown dramatically reduced 
the number and size of tumorspheres in MDA-MB157 and 
SUM159 cells (Figure 4E).
To further investigate the roles of Dub3, we examined 
whether Dub3 expression can confer luminal breast cancer 
cells with EMT phenotypes. MCF7 and T47D cells are 
typical luminal cells with little endogenous Dub3 expression. 
Expression of Dub3 in these two cell lines dramatically 
increased the levels of Slug and Twist (Figure 5A) and 
reduced E-cadherin and ER expression. Concomitantly, Dub3 
expression induced significant morphology changes as cells 
turned into a scattered appearance indicative of EMT (Figure 
5B). As expected, Dub3 expression dramatically enhanced 
the migratory and invasive capabilities of both MCF7 and 
T47D cells (Figure 5C-5D). However, CS-Dub3 lost the 
ability to increase cell migration and invasion in these cells. 
Together these results indicated that Dub3 is a critical EMT-
promoting factor that can increase migration, invasion and 
CSC-like properties of breast cancer cells.
Dub3 is critical for IL-6-induced EMT
Dub3 was identified as an early response gene that 
can be induced by IL-6 [22, 23]. Importantly, IL-6 can 
induce EMT through the STAT3 signaling, and its level 
increases with higher breast tumor grade and correlates 
with metastasis and poor patient survival [26, 27]. To test 
whether IL-6 promotes EMT through induction of Dub3 
and subsequently results in Slug and Twist stabilization, 
we treated SUM159 cells with IL-6 at different time 
intervals. Consistent with previous findings, Dub3 was 
rapidly induced after one hour of IL-6 stimulation, which 
was accompanied by an increase of Slug and Twist 
protein levels (Figure 6A). In contrast, Dub3-knockdown 
almost completely abolished IL-6 induced Slug and Twist 
upregulation in SUM159 cells (Figure 6B). We also found 
that a Dub3 inhibitor, WP1130, can dramatically suppress 
Slug and Twist upregulation induced by IL-6 while PR619 
(a deubiquitinating enzyme inhibitor) was less effective 
in SUM159 cells (Figure 6C) [28, 29]. Furthermore, 
Dub3-knockdown or WP1130 treatment significantly 
inhibited IL-6-mediated invasion of tumor cells (Figure 
6D); however, WP1130 could not suppress IL-6-induced 
invasion in Dub3-knockdown cells. Together, these 
data support the idea that Dub3 functions as a molecule 
sensor, which can stabilize Slug/Twist and induce EMT in 
responding to microenvironmental IL-6 stimulation.
Dub3, Slug and Twist are coordinately expressed 
in breast tumors
To find out whether the expression of Dub3, Slug and 
Twist are correlated in breast cancer, we examined their 
expression in multiple breast cancer cell lines and tumor 
specimens. As expected, Dub3, Slug and Twist levels are 
coordinately high in BLBC cell lines compared to luminal 
breast cancer cell lines (Figure 7A). We also performed 
immunohistochemistry (IHC) analysis to examine their 
expression in primary breast tumor specimens. Although 
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Figure 2: Dub3 interacts with Slug and Twist. (A) Flag-Slug or HA-Twist was co-expressed with Myc-Dub3 in HEK293 cells. 
Slug-Dub3 or Twist-Dub3 complexes were immunoprecipitated with either Myc, HA or Flag antibody, and the associated proteins 
were examined by western blot analysis using HA, Flag and Myc antibody, respectively. (B) Endogenous Dub3 and Slug or Twist were 
immunoprecipitated from MDA-MB157 and SUM159 cells, and the bound endogenous Slug/Twist and Dub3 were examined by western 
blot analysis. (C) EGFP-Slug or EGFP-Twist was co-expressed with Myc-Dub3 in HEK293 cells. After fixation and staining, the cellular 
location of Slug/Twist (green) and Dub3 (red) was visualized with confocal microscopy. Scale bar = 5 μm.
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we could not detect Slug expression in these tumor samples 
due to the lack of specific antibodies, we found a significant 
correlation of Dub3 and Twist in terms of protein intensity 
and distribution in these breast tumor specimens (Figure 
7B). The tumor-staining data support our findings in cell-
culture experiments and further strengthen our notion that 
Dub3 is a critical deubiquitinase in stabilizing Slug and 
Twist in breast cancer.
Figure 3: Dub3 de-ubiquitinates Slug and Twist. (A) Flag-Slug or HA-Twist was co-expressed with Myc-Dub3 or control vector in 
HEK293 cells. After the cells were treated with cycloheximide (CHX) for indicated time intervals, expression of Slug, Twist and Dub3 was 
examined by western blot analysis. (B) MDA-MB157 cells stably transfected with control or Dub3 shRNA were treated with CHX. Expression 
of endogenous Slug, Twist and Dub3 was examined. The intensity of Slug/Twist expression for each time point was quantified by densitometry 
and plotted (bottom panel). The experiment was repeated three times and a representative experiment is presented. *p value < 0.001; (C) Flag-
Slug or Flag-Twist was co-expressed with HA-ubiquitin and either WT or CS Dub3 in HEK293 cells. After cells were treated with MG132, 
Slug and Twist proteins were immunoprecipitated and poly-ubiquitination of Slug and Twist detected by western blot analysis using HA 
antibody. (D) MDA-MB157 and SUM159 cells stably transfected with control or Dub3 shRNA were treated with MG132. Cell extracts were 
immunoprecipitated with Slug or Twist antibody and the poly-ubiquitination of Slug and Twist detected by western blot analysis.
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Figure 4: Knockdown of Dub3 inhibits migration, invasion and CSC-like characteristics of BLBC cells. (A) MDA-
MB157 and SUM159 cells stably transfected with control or Dub3 shRNA were examined by western blot analysis for expression of 
various protein markers as indicated. (B) The mRNA levels of various markers as indicated were quantitated by real-time PCR (mean ± SD 
in three separate experiments). (C) Wound healing assay of MDA-MB157 and SUM159 cells with or without stable knockdown of Dub3. 
Data were presented as mean ± SEM. (D) Boyden chamber invasion assay of MDA-MB157 and SUM159 cells with or without stable 
knockdown of Dub3. Data were presented as mean ± SEM. (E) Quantification of tumorsphere from MDA-MB157 and SUM159 cells stably 
expressing control or Dub3 shRNA (mean ± SD from three independent experiments) (left panel). Representative images were shown (right 
panel). Scale bar = 100 μm. **p value < 0.01; *p value <0.05.
Oncotarget75134www.impactjournals.com/oncotarget
DISCUSSION
Metastasis remains a daunting threat, as 
approximately 90% of cancer deaths are caused by the 
spread of tumor cells to other organs [30]. BLBC carries 
the poorest prognosis among breast cancer subtypes, given 
its tendency toward early and recurrent metastasis and lack 
of effective targeted therapies [31-35]. BLBC intrinsically 
activates EMT in response to various signaling from 
microenvironment, particularly those from inflammatory 
cytokines. Similar to many transcription factors, such 
as p53 and HIF1α, EMT-TFs like Snail, Slug and Twist 
are often subjected to ubiquitination/degradation and 
have very short half-lives. Several ubiquitin ligases have 
so far been linked to the degradation of EMT-TFs. For 
example, β-TrCP1 has been shown to mediate cytoplasmic 
degradation of Snail [14, 36]. To be targeted by ubiquitin 
ligase machinery, a protein usually contains a degradation 
Figure 5: Overexpression of Dub3 induces EMT. (A) Dub3 was stably transduced in MCF7 and T47D cells and the indicated 
proteins were examined by western blot analysis. (B) MCF7 and T47D cells with Dub3 overexpression were examined for morphologic 
changes as well as expression of E-cadherin, ER α and Dub3 with IF. (C) Boyden chamber migration assay of MCF7 and T47D cells with 
Dub3 WT or CS mutant expression. Data were presented as mean ± SEM. (D) Boyden chamber invasion assay of MCF7 and T47D cells 
with Dub3 WT or CS mutant expression. Data were presented as mean ± SEM. Scale bar = 100 μm. *p value < 0.001; #p value > 0.05.
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signal or degron. As for Snail, the degron lies in the 
β-TrCP1 destruction box DSGXXS at the central region, 
with the two serine residues phosphorylated by GSK-3β 
[14]. The lysine residues modified by β-TrCP1 have also 
been identified as K98, K137 and K146 [37]. Interestingly, 
Slug and Twist are also subject to ubiquitination and 
degradation mediated by β-TrCP1, although the classical 
destruction motif is absent [17, 38]. In addition to 
β-TrCP1, Fbxl14 is considered a common regulator of 
Snail/Slug, Twist and ZEB family members [37, 39, 40]. 
Slug and Twist interact with Fbxl14 through the C-terminal 
WR domain and an N-terminal hydrophobic sequence, 
respectively [39, 40]. Furthermore, Fbxl5 exerts its E3 
ligase function specifically on Snail and Slug [41]. In spite 
of these findings, little was known about how the reversal 
de-ubiquitination process might rescue these EMT-TFs 
from the fate of degradation during EMT and metastasis. 
Recently, we and others have identified Dub3 functions as 
a Snail deubiquitinase and blocks the activity of β-TrCP1 
and Fbxl14 to stabilize Snail [29, 42]; however, it remains 
unclear whether Dub3 can also remove the ubiquitination 
of Slug and Twist, given that these EMT-TFs share a 
common ubiquitin E3 ligase β-TrCP1 and Fbxl14. Our 
current results demonstrated that Dub3 interacts with Slug 
and Twist and prevents Slug and Twist from degradation 
mediated by these E3 ligases. The “Ying-Yang” control 
model proposed here greatly strengthens the concept of 
cellular plasticity and heterogeneity in EMT (Figure 
7C). It mirrors the prominent idea of “partial EMT”, 
which centers on cells hovering between epithelial and 
mesenchymal states as they migrate, therefore retaining 
greater flexibility to switch back through MET to fulfil 
Figure 6: IL-6-induced BLBC cells invasion is mediated by Dub3. (A) SUM159 cells were starved overnight and treated with 
IL-6 for the indicated time intervals and the expression of Dub3, Slug and Twist were examined by western blot analysis. (B) SUM159 
cells stably transduced with either control or Dub3 shRNA were starved and treated with IL-6 and the expression of Slug and Twist was 
examined. (C) SUM159 cells were pre-treated with DMSO, WP1130 or PR619 for half hour. The cells were then treated with IL-6 (50ng/
ml) and the expression of Slug and Twist was examined by western blot analysis. (D) SUM159 cells stably transduced with control or 
Dub3 shRNA were pre-treated with DMSO or WP1130 for half hour. Boyden chamber invasion assay was performed with or without IL-6 
induction. Data were presented as mean ± SEM. Scale bar = 100 μm. **p value < 0.01; *p value <0.05; #p value > 0.05.
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metastatic colonization. In this regard, the balance 
between degradation and stabilization of EMT-TFs may 
oscillate under extremely dynamic cellular contexts, which 
warrants further investigation.
Furthermore, we found that Dub3 is responsible 
for Slug and Twist stabilization and EMT induction in 
BLBC cells, and its expression positively correlates with 
Twist level in human breast tumor samples. In addition, 
Dub3 can be rapidly induced by inflammatory cytokine 
IL-6 [22, 23]. Elevated IL-6 has been shown to confer 
cancer cells with chemotherapy resistance and contribute 
to tumor recurrence and metastasis [26, 27]. As IL-6 is 
highly expressed in BLBC cells as well as infiltrated 
tumor-associated macrophages (TAMs) [43], it may 
exert its function of Dub3 activation through autocrine 
and paracrine loops. Interestingly, IL-6 can stimulate 
casein kinase 2 (CK2)-mediated phosphorylation and 
stabilization of Twist in head and neck cancer cells [44]. 
In the current study, we identified a novel connection 
between IL-6 and Slug/Twist stabilization in BLBC cells 
specifically mediated by Dub3. In this regard, Dub3 may 
represent an excellent example of a molecular sensor 
that relays environmental signals to intracellular EMT-
TFs for the induction of EMT. Interestingly, tumor 
microenvironment produces cytokines, chemokines 
and growth factors, including TNFα, TGFβ, IL-6, FGF, 
epidermal growth factor (EGF), and HGF. These factors 
initiate and propel tumor metastasis through induction of 
Figure 7: Dub3, Slug and Twist are coordinately expressed in breast tumors. (A) Expression of Dub3, Slug and Twist was 
examined in multiple breast cancer cell lines. (B) Breast tumor surgical specimens were immunostained using antibodies against Dub3 and 
Twist. Representative images of IHC staining from the same tumor samples were shown in the top panel and statistical analysis shown in 
the bottom panel. (C) The proposed model of the counteracting effect of Dub3 and E3 ligases of Slug and Twist in mediating EMT and 
metastasis. Scale bar = 100 μm.
Oncotarget75137www.impactjournals.com/oncotarget
EMT [45]. Here we have demonstrated that IL-6 promotes 
metastasis through Dub3 induction. Dub3 can also be 
induced in response to IL-4 stimulation [23, 46]. Whether 
other cytokines and/or growth factors may also induce 
tumor invasion and metastasis via Dub3 is an important 
area that requires further investigations.
Finally, the discovery of the role of Dub3 in 
controlling EMT-TFs brings out new therapeutic 
indications. Development of Slug and Twist-targeting 
inhibitors would encounter formidable obstacles due to 
their lack of ligand-binding domains. Our study propels 
alternative approaches, i.e., design of specific Dub3 
enzymatic inhibitors or Dub3-Slug/Twist protein complex-
disrupting molecules. Indeed, we found that application 
of WP1130, a Dub3 inhibitor, not only significantly 
suppressed Slug and Twist upregulation induced by IL-6 
in BLBC cells, but also inhibited the IL-6-induced cell 
invasion. Our study highlights the perspectives of small 
molecule compounds that target the IL-6-Dub3-Slug/
Twist signaling axis with high specificity and efficiency in 
treatment of tumor metastasis.
MATERIALS AND METHODS
Plasmids and reagents
Both HA-tagged and Flag-tagged full length Twist 
and Slug were cloned into pcDNA3.0. In addition, full 
length Twist and Slug were cloned into pEGFP-N1. The 
WT Dub3 construct was purchased from Addgene. CS 
Dub3 was generated using the QuikChange Mutagenesis 
kit (Stratagene, La Jolla, CA, USA) as described 
previously [47]. All sequences were verified by DNA 
sequencing. The antibodies used include: anti-Flag, anti-
Actin, anti-Myc (Sigma-Aldrich, St. Louis, MO, USA), 
anti-Dub3 (Abcam), anti-Ub (Millipore), N-cadherin 
(Upstate), anti-Slug, anti-Twist (Cell Signaling), anti-
Vimentin, anti-ERα (Neomarkers), anti-HA (Roche), anti-
E-cadherin, anti-Claudin-7 (BD Bioscience). Dub3 shRNA 
expression plasmids were purchased from MISSION 
shRNA at Sigma-Aldrich (St. Louis, MO, USA). WP1130 
and PR619 were from Selleck. Smartpool siRNA against 
human Dub3 was from Dharmacon (Chicago, IL, USA).
Cell culture
The human embryonic kidney HEK293, and breast 
cancer cell lines, MDA-MB157, MCF7 were purchased 
from the American Type Culture Collection (Manassas, 
VA, USA) and grown in Dulbecco’s modified Eagle’s/
F12 medium plus 10% fetal bovine serum as described 
previously. Breast cancer cell lines T47D were grown 
in RPMI1640 plus 10% FBS. The culture medium for 
SUM159 is Ham’s F-12 (Invitrogen) supplemented with 
5% FBS, 5 μg/mL insulin, and 1 μg/mL hydrocortisone 
(both from Sigma, St. Louis, MO, USA).
Immunoprecipitation and western blot analysis
For protein extraction, 5 × 105 cells/well were 
plated onto six-well plates and transiently transfected with 
indicated expression plasmids. 48 h after transfection, cells 
were incubated with or without the proteasome inhibitor 
MG132 (10 μM) for an additional 6 h before protein 
extraction and western blot analysis. Primary antibodies 
against Flag (M2, 1:1000) and HA (3F10, 1:4000) were 
used for protein detection. For immunoprecipitation (IP), 
cells were lysed in IP buffer (50 mM Tris (pH 7.5), 150 
mM NaCl, 5 μg/ml aprotinin, 1 μg/ml pepstatin, 1% NP-
40, 1 mM EDTA and 0.25% deoxycholate). Pre-cleared 
cell lysates were incubated overnight with 1 μg of anti-HA 
or anti-Flag antibody conjugated to agarose beads (Roche 
Molecular Biochemicals) at 4°C. The beads were then 
washed with PBS, and the immunoprecipitated protein 
complexes were resolved by 10% SDS–PAGE.
In vivo ubiquitination assay
HEK293 cells were transfected with HA-ubiquitin, 
Myc-Dub3 and Flag-Twist or Flag-Slug plasmids as 
indicated. After 48 hours of transfection the cells were 
treated with 10 μM MG132 for 6 hours. The cells lysates 
were immunoprecipitated using anti-Flag agarose (Sigma).
Immunofluorescence staining
For immunofluorescence microscopy, cells 
transfected with Myc-Dub3 and EGFP-Twist or EGFP-Slug 
were grown on cover slips, fixed with 4% paraformaldehyde 
and incubated overnight with anti-Myc antibody. Proteins 
were visualized by incubation with goat anti-mouse 
conjugated with Alexa Fluor 568 (Invitrogen, Carlsbad, CA, 
USA). Finally, cells on cover slips were incubated with 4′, 
6′-diamidino-2-phenylindole (Sigma-Aldrich) for 20 min 
and visualized with a confocal microscope.
Quantitative real-time PCR
Total RNA was isolated using RNeasy Mini kit 
(Qiagen) according to the manufacturer’s instructions. 
Specific quantitative real-time PCR experiments were 
performed using SYBR Green Power Master Mix 
following manufacturer’s protocol (Applied Biosystems).
Invasion assay
Invasion assays were performed in Boyden 
chambers coated with Matrigel (BD biosciences, San 
Jose, CA, USA). Cancer cells were seeded on top of the 
Matrigel in the upper chamber while the bottom chambers 
were filled with non-serum culture medium plus 100 nM 
Lysophosphatidic acid (LPA). The invasive cancer cells 
were stained with crystal violent. All experiments were 
performed in triplicate.
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Tumorsphere-formation assay
Tumorsphere cultures were performed as described 
in Dontu et al [48]. In brief, Cell monolayers were plated 
as single-cell suspensions on ultra-low attachment plates 
(Corning) in DMEM/F12 medium supplemented with 20 
ng/ml EGF, 10 μg/ml insulin, 0.5 μg/ml hydrocortisone 
and B27. Tumorspheres were counted via visual inspection 
after 5-10 days.
Immunohistochemical (IHC) staining
Breast cancer TMA was purchased from US Biomax 
and Pantomics containing 160 cases of breast cancer. 
Tissue samples were stained with anti-Dub3 (Abcam) and 
anti-Twist antibodies (BD company) and each sample was 
scored by an H-score method that combines the values of 
immunoreaction intensity and the percentage of tumor cell 
staining as described previously [49]. In brief, a composite 
staining index is the product staining intensity (range 0-3) 
and staining percentage of tumor cell sin each core. The 
results were ranked in three expression levels: high (3+), 
Low (2+), and negative (0-1+). Chi-square analysis was 
used to analyze the relationship between Dub3 and Twist 
expression; statistical significance was defined as P<0.05.
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